Physician profile
Gary L Treece
NPI 1447269857
$805.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $198 · 2021: $208 · 2022: $139 · 2023: $34.53 · 2024: $79.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.25 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.25 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.34 | 2019-2022 | |
| Abbott Laboratories | $78.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $70.81 | 2020-2021 | |
| Amgen INC. | $66.60 | 2020-2024 | Tepezza |
| Dexcom, INC. | $63.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $59.31 | 2019-2024 | |
| Electromed, INC. | $56.62 | 2022 | |
| Novo Nordisk INC | $47.31 | 2019-2021 | |
| Pfizer INC. | $39.99 | 2024 | |
| Glaxosmithkline, LLC. | $39.57 | 2021 | |
| Medtronic Minimed, INC. | $34.22 | 2019-2020 | |
| Lilly USA, LLC | $30.24 | 2019-2021 | |
| Horizon Therapeutics Plc | $27.04 | 2021-2023 | Tepezza |
| Echosens North America, INC. | $20.63 | 2023 | Fibroscan |
| Merck Sharp & Dohme LLC | $16.71 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.08 | 2021 | |
| Lundbeck LLC | $14.93 | 2020 | |
| Sunovion Pharmaceuticals INC. | $14.53 | 2021 | |
| Hologic Sales and Service, LLC | $12.69 | 2021 | |
| Radius Health, INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Treece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.